Omicron is more transmissible but may not cause as much severe illness, experts say.
Author: Karen Weintraub, USA TODAY
Could treatments for rare diseases be found in neighborhood pharmacies? New uses for old drugs offer promise
For patients with extremely rare diseases, repurposing existing drugs may be their only hope.
A year after first COVID-19 vaccine, here’s what’s next for researchers – and what worries them
On the one year anniversary of the first COVID vaccines being given, what do researchers have their sights set on? Perhaps, a future without shots.
FDA panel narrowly recommends authorization of first antiviral to treat COVID-19
The drug, molnupiravir from Merck, is intended to be used in people at risk for severe COVID-19. The FDA panel authorized its use by a vote of 13-10.
CDC makes COVID vaccine boosters available for all US adults, recommends for 50 and older
CDC Director Dr. Rochelle Walensky signed off on the advisory panel’s recommendations on Friday night, making them federal policy.
COVID booster doses could be authorized by Friday, ‘should be a priority’ for US adults, experts say
The CDC has said it’s safe to mix vaccine brands, and data suggests Pfizer-BioNTech or Moderna would be more protective than a second J&J shot.
Pfizer antiviral drug could nearly end deaths from COVID-19, company study suggests
When given within 5 days of the onset of symptoms, Pfizer’s antiviral therapy, Paxlovid, prevented nearly 90% of deaths from COVID, a new study finds.
Kids getting sick with COVID-19 is far riskier than rare side effect myocarditis, experts say
Myocarditis is possible in kids who get COVID-19 vaccines, but less likely than in teens or young adults. Getting COVID is much riskier, experts say.
Parents of children 5-11 will soon face a decision on COVID vaccination: What we know, and don’t know
The Pfizer-BioNTech COVID vaccine could become available for children ages 5 to 11 as soon as next week. Here’s what we know, and don’t know.
Do you need another shot? Can you mix and match vaccines? COVID booster questions, answered.
COVID-19 boosters are expected to become widely available in the coming days and everyone eligible will be able to choose their preferred vaccine.